{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:41:23Z","timestamp":1793112083114,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Elite Medical Professionals Project of China-Japan Friendship Hospital","award":["ZRJY2023-GG06"],"award-info":[{"award-number":["ZRJY2023-GG06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04531-3","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:53:49Z","timestamp":1764140029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Abelmoschus manihot alleviates insulin resistance in diabetic kidney disease through attenuation of inflammation"],"prefix":"10.1186","volume":"27","author":[{"given":"Xiansen","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"9","key":"4531_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, Coresh J, Zhao MH, Wang H. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905\u20136.","journal-title":"N Engl J Med"},{"key":"4531_CR2","doi-asserted-by":"publisher","first-page":"1526482","DOI":"10.3389\/fendo.2025.1526482","volume":"16","author":"K Xie","year":"2025","unstructured":"Xie K, Cao H, Ling S, Zhong J, Chen H, Chen P, Huang R. Global, regional, and National burden of chronic kidney disease, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Front Endocrinol (Lausanne). 2025;16:1526482.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"4531_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804\u201314.","journal-title":"Nat Med"},{"issue":"5\u20136","key":"4531_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.346312.120","volume":"35","author":"YS Lee","year":"2021","unstructured":"Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021;35(5\u20136):307\u201328.","journal-title":"Genes Dev"},{"key":"4531_CR5","doi-asserted-by":"publisher","first-page":"101154","DOI":"10.1016\/j.molmet.2020.101154","volume":"45","author":"CE Shannon","year":"2021","unstructured":"Shannon CE, Ragavan M, Palavicini JP, Fourcaudot M, Bakewell TM, Valdez IA, Ayala I, Jin ES, Madesh M, Han X, Merritt ME, Norton L. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease. Mol Metab. 2021;45:101154.","journal-title":"Mol Metab"},{"issue":"10","key":"4531_CR6","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/ndt\/gfh207","volume":"19","author":"S Mezzano","year":"2004","unstructured":"Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J. Nf-kappab activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transpl. 2004;19(10):2505\u201312.","journal-title":"Nephrol Dial Transpl"},{"key":"4531_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fphar.2020.01068","volume":"11","author":"F Luan","year":"2020","unstructured":"Luan F, Wu Q, Yang Y, Lv H, Liu D, Gan Z, Zeng N. Traditional uses, chemical constituents, biological properties, clinical settings, and toxicities of Abelmoschus manihot l.: a comprehensive review. Front Pharmacol. 2020;11:1068.","journal-title":"Front Pharmacol"},{"key":"4531_CR8","doi-asserted-by":"publisher","first-page":"1288159","DOI":"10.3389\/fphar.2023.1288159","volume":"14","author":"Y Tan","year":"2023","unstructured":"Tan Y, Zhang Z, Zhou P, Zhang Q, Li N, Yan Q, Huang L, Yu J. Efficacy and safety of Abelmoschus manihot capsule combined with acei\/arb on diabetic kidney disease: a systematic review and meta analysis. Front Pharmacol. 2023;14:1288159.","journal-title":"Front Pharmacol"},{"key":"4531_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.phymed.2018.12.021","volume":"57","author":"W Han","year":"2019","unstructured":"Han W, Ma Q, Liu Y, Wu W, Tu Y, Huang L, Long Y, Wang W, Yee H, Wan Z, Tang R, Tang H, Wan Y. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting nlrp3 inflammasome activation and tlr4\/nf-\u03bab signaling. Phytomedicine. 2019;57:203\u201314.","journal-title":"Phytomedicine"},{"issue":"7","key":"4531_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"4","key":"4531_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, No\u00ebl LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"4531_CR12","doi-asserted-by":"publisher","first-page":"1427727","DOI":"10.3389\/fendo.2024.1427727","volume":"15","author":"H Zhu","year":"2024","unstructured":"Zhu H, Chen Y, Ding D, Chen H. Association between different insulin resistance indices and all-cause mortality in patients with diabetic kidney disease: a prospective cohort study. Front Endocrinol (Lausanne). 2024;15:1427727.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"4531_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2337\/dc22-0202","volume":"45","author":"T Wang","year":"2022","unstructured":"Wang T, Li M, Zeng T, Hu R, Xu Y, Xu M, Zhao Z, Chen Y, Wang S, Lin H, Yu X, Chen G, Su Q, Mu Y, Chen L, Tang X, Yan L, Qin G, Wan Q, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Zhao J, Shi L, Ning G, Bi Y, Wang W, Lu J. Association between insulin resistance and cardiovascular disease risk varies according to glucose tolerance status: a nationwide prospective cohort study. Diabetes Care. 2022;45(8):1863\u201372.","journal-title":"Diabetes Care"},{"issue":"5","key":"4531_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2337\/db05-1484","volume":"55","author":"AI Parvanova","year":"2006","unstructured":"Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A, Remuzzi G, Ruggenenti P. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes. 2006;55(5):1456\u201362.","journal-title":"Diabetes"},{"issue":"2","key":"4531_CR15","doi-asserted-by":"publisher","first-page":"F312","DOI":"10.1152\/ajprenal.00451.2016","volume":"312","author":"MV \u00d8stergaard","year":"2017","unstructured":"\u00d8stergaard MV, Pinto V, Stevenson K, Worm J, Fink LN, Coward RJ. Dba2j db\/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance. Am J Physiol Ren Physiol. 2017;312(2):F312\u201321.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"4531_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI88880","volume":"127","author":"H Wu","year":"2017","unstructured":"Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43\u201354.","journal-title":"J Clin Invest"},{"issue":"2","key":"4531_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fern\u00e1ndez C, Marchant V, Donate-Correa J, Navarro-Gonz\u00e1lez JF, Ortiz A, Ruiz-Ortega M. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2023;103(2):282\u201396.","journal-title":"Kidney Int"},{"issue":"1","key":"4531_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ptr.6818","volume":"35","author":"N Li","year":"2021","unstructured":"Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of abelmoschus manihot flowers in treatment of kidney diseases. Phytother Res. 2021;35(1):198\u2013206.","journal-title":"Phytother Res"},{"issue":"11","key":"4531_CR19","doi-asserted-by":"publisher","first-page":"e22017","DOI":"10.1016\/j.heliyon.2023.e22017","volume":"9","author":"C Wei","year":"2023","unstructured":"Wei C, Wang C, Li R, Bai Y, Wang X, Fang Q, Chen X, Li P. The Pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease. Heliyon. 2023;9(11):e22017.","journal-title":"Heliyon"},{"key":"4531_CR20","doi-asserted-by":"publisher","first-page":"115899","DOI":"10.1016\/j.biopha.2023.115899","volume":"169","author":"H Yu","year":"2023","unstructured":"Yu H, Tang H, Wang M, Xu Q, Yu J, Ge H, Qiang L, Tang W, Gu HF. Effects of total flavones of Abelmoschus manihot (l.) on the treatment of diabetic nephropathy via the activation of solute carriers in renal tubular epithelial cells. Biomed Pharmacother. 2023;169:115899.","journal-title":"Biomed Pharmacother"},{"key":"4531_CR21","doi-asserted-by":"publisher","first-page":"667644","DOI":"10.3389\/fphar.2021.667644","volume":"12","author":"BH Liu","year":"2021","unstructured":"Liu BH, Tu Y, Ni GX, Yan J, Yue L, Li ZL, Wu JJ, Cao YT, Wan ZY, Sun W, Wan YG. Total flavones of Abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting mettl3-dependent m(6)a modification-mediated nlrp3-inflammasome activation and pten\/pi3k\/akt signaling. Front Pharmacol. 2021;12:667644.","journal-title":"Front Pharmacol"},{"issue":"7","key":"4531_CR22","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.2337\/dc22-0607","volume":"45","author":"J Zhao","year":"2022","unstructured":"Zhao J, Tostivint I, Xu L, Huang J, Gambotti L, Boffa JJ, Yang M, Wang L, Sun Z, Chen X, Liou-Schischmanoff A, Baumelou A, Ma T, Lu G, Li L, Chen D, Pi\u00e9roni L, Liu B, Qin X, He W, Wang Y, Gu HF, Sun W. Efficacy of combined Abelmoschus manihot and Irbesartan for reduction of albuminuria in patients with type 2 diabetes and diabetic kidney disease: a multicenter randomized double-blind parallel controlled clinical trial. Diabetes Care. 2022;45(7):e113\u20135.","journal-title":"Diabetes Care"},{"issue":"9","key":"4531_CR23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4049\/jimmunol.2200900","volume":"210","author":"WC McCarthy","year":"2023","unstructured":"McCarthy WC, Sherlock LG, Grayck MR, Zheng L, Lacayo OA, Solar M, Orlicky DJ, Dobrinskikh E, Wright CJ. Innate immune zonation in the liver: nf-\u03bab (p50) activation and c-reactive protein expression in response to endotoxemia are zone specific. J Immunol. 2023;210(9):1372\u201385.","journal-title":"J Immunol"},{"issue":"9","key":"4531_CR24","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.2741\/3467","volume":"14","author":"G Rangan","year":"2009","unstructured":"Rangan G, Wang Y, Harris D. Nf-kappab signalling in chronic kidney disease. Front Biosci (Landmark Ed). 2009;14(9):3496\u2013522.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"4531_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/hep.24011","volume":"53","author":"L Xi","year":"2011","unstructured":"Xi L, Xiao C, Bandsma RH, Naples M, Adeli K, Lewis GF. C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology. 2011;53(1):127\u201335.","journal-title":"Hepatology"},{"issue":"23","key":"4531_CR26","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1161\/01.CIR.0000041046.32962.86","volume":"106","author":"T McLaughlin","year":"2002","unstructured":"McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P. Differentiation between obesity and insulin resistance in the association with c-reactive protein. Circulation. 2002;106(23):2908\u201312.","journal-title":"Circulation"},{"issue":"6","key":"4531_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1538-7836.2007.02527.x","volume":"5","author":"G Kaur","year":"2007","unstructured":"Kaur G, Rao LV, Agrawal A, Pendurthi UR. Effect of wine phenolics on cytokine-induced c-reactive protein expression. J Thromb Haemost. 2007;5(6):1309\u201317.","journal-title":"J Thromb Haemost"},{"key":"4531_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2019.09.024","volume":"145","author":"Y Hu","year":"2019","unstructured":"Hu Y, Gui Z, Zhou Y, Xia L, Lin K, Xu Y. Quercetin alleviates rat osteoarthritis by inhibiting inflammation and apoptosis of chondrocytes, modulating synovial macrophages polarization to m2 macrophages. Free Radic Biol Med. 2019;145:146\u201360.","journal-title":"Free Radic Biol Med"},{"key":"4531_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biopha.2016.11.134","volume":"86","author":"W Wang","year":"2017","unstructured":"Wang W, Wu QH, Sui Y, Wang Y, Qiu X. Rutin protects endothelial dysfunction by disturbing nox4 and ros-sensitive nlrp3 inflammasome. Biomed Pharmacother. 2017;86:32\u201340.","journal-title":"Biomed Pharmacother"},{"key":"4531_CR30","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.2147\/DDDT.S264898","volume":"14","author":"L Gu","year":"2020","unstructured":"Gu L, Hong F, Fan K, Zhao L, Zhang C, Yu B, Chai C. Integrated network Pharmacology analysis and Pharmacological evaluation to explore the active components and mechanism of Abelmoschus manihot (l.) Medik. On renal fibrosis. Drug Des Devel Ther. 2020;14:4053\u201367.","journal-title":"Drug Des Devel Ther"},{"key":"4531_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jep.2015.07.036","volume":"173","author":"ZM Mao","year":"2015","unstructured":"Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, Huang MM, Yang JJ, Wu W, Tang HT, Tang RM. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38mapk\/akt pathways, compared to \u03b1-lipoic acid. J Ethnopharmacol. 2015;173:256\u201365.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"4531_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","volume":"149","author":"BL Neuen","year":"2024","unstructured":"Neuen BL, Heerspink H, Vart P, Claggett BL, Fletcher RA, Arnott C, de Oliveira CJ, Falster MO, Pearson SA, Mahaffey KW, Neal B, Agarwal R, Bakris G, Perkovic V, Solomon SD, Vaduganathan M. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with sglt2 inhibitors, glp-1 receptor agonists, and nonsteroidal Mra compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation. 2024;149(6):450\u201362.","journal-title":"Circulation"},{"issue":"6","key":"4531_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa2410659","volume":"393","author":"R Agarwal","year":"2025","unstructured":"Agarwal R, Green JB, Heerspink H, Mann J, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M. Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes. N Engl J Med. 2025;393(6):533\u201343.","journal-title":"N Engl J Med"},{"issue":"1","key":"4531_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","volume":"97","author":"E van Bommel","year":"2020","unstructured":"van Bommel E, Muskiet M, van Baar M, Tonneijck L, Smits MM, Emanuel AL, Bozovic A, Danser A, Geurts F, Hoorn EJ, Touw DJ, Larsen EL, Poulsen HE, Kramer M, Nieuwdorp M, Joles JA, van Raalte DH. The renal hemodynamic effects of the sglt2 inhibitor Dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind red trial. Kidney Int. 2020;97(1):202\u201312.","journal-title":"Kidney Int"},{"issue":"1","key":"4531_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-022-01476-x","volume":"21","author":"AD Kaze","year":"2022","unstructured":"Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. Association of sglt2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022;21(1):47.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04531-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T20:04:20Z","timestamp":1767470660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04531-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4531"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04531-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7003564\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of China-Japan Friendship Hospital (2021-113-K71-1). All methods were carried out in accordance with relevant guidelines and regulations. Due to the retrospective retrieval of the patients data, the informed consent was waived. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}